Clinical Trials Browser

Phase 2 × Lymphoma × Everolimus × Clear all

NCT04305444 2025-01-08

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Leukemia, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00702052 2021-05-25

PILLAR-1

Phase 2 Completed

58 enrolled 11 charts

Lymphoid

Lymphoma, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT01022996 2016-05-18

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Phase 2 Completed

57 enrolled 10 charts

Lymphoid

Hemic and Lymphatic Diseases, Hodgkin Disease, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms by Histologic Type

NCT00516412 2015-09-29

Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Completed

35 enrolled

Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT00727207 2012-12-17

Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

Phase 2 Terminated

35 enrolled

Lymphoid

Lymphoma, Lymphoma, Mantle-Cell